NovoCure (NVCR) Total Liabilities (2014 - 2026)
NovoCure recorded quarterly Total Liabilities of $457.2 million in Q1 2026, down 1.43% quarter-over-quarter from $463.9 million in Q4 2025, and down 48.45% year-over-year from $886.9 million in Q1 2025.
NovoCure's Total Liabilities history runs 13 years deep, the most recent figure standing at $457.2 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 48.45% year-over-year to $457.2 million; the TTM figure through Mar 2026 stood at $457.2 million (down 48.45% YoY), while the FY2025 annual figure was $463.9 million, down 47.32% from the prior year.
- Total Liabilities came in at $457.2 million for Q1 2026 at NovoCure, down from $463.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q3 2025 to a low of $457.2 million in Q1 2026.
- A 5-year average of $765.6 million and a median of $752.6 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities advanced 18.42% in 2025 and plunged 48.45% in 2026, its largest moves.
- NovoCure's Total Liabilities stood at $750.5 million in 2022, then climbed by 4.42% to $783.6 million in 2023, then climbed by 12.37% to $880.6 million in 2024, then tumbled by 47.32% to $463.9 million in 2025, then retreated by 1.43% to $457.2 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $457.2 million, $463.9 million, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 57.73 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 18.25 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 18.55 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.68 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.54 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 457.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 457.21 Mn |
| Dec 31, 2025 | 463.86 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 896.43 Mn |
| Mar 31, 2025 | 886.85 Mn |
| Dec 31, 2024 | 880.61 Mn |
| Sep 30, 2024 | 861.21 Mn |
| Jun 30, 2024 | 850.42 Mn |
| Mar 31, 2024 | 762.07 Mn |
| Dec 31, 2023 | 783.63 Mn |
| Sep 30, 2023 | 752.65 Mn |
| Jun 30, 2023 | 743.33 Mn |
| Mar 31, 2023 | 742.19 Mn |
| Dec 31, 2022 | 750.48 Mn |
| Sep 30, 2022 | 728.81 Mn |
| Jun 30, 2022 | 721.00 Mn |
| Mar 31, 2022 | 714.33 Mn |
| Dec 31, 2021 | 729.00 Mn |
| Sep 30, 2021 | 707.29 Mn |
| Jun 30, 2021 | 699.79 Mn |
| Mar 31, 2021 | 695.50 Mn |
| Dec 31, 2020 | 575.46 Mn |
| Sep 30, 2020 | 124.01 Mn |
| Jun 30, 2020 | 261.12 Mn |
| Mar 31, 2020 | 260.50 Mn |
| Dec 31, 2019 | 261.66 Mn |
| Sep 30, 2019 | 253.49 Mn |
| Jun 30, 2019 | 247.28 Mn |
| Mar 31, 2019 | 243.86 Mn |
| Dec 31, 2018 | 227.53 Mn |
| Sep 30, 2018 | 200.58 Mn |
| Jun 30, 2018 | 197.80 Mn |
| Mar 31, 2018 | 197.36 Mn |
| Dec 31, 2017 | 151.73 Mn |
| Sep 30, 2017 | 145.59 Mn |
| Jun 30, 2017 | 139.50 Mn |
| Mar 31, 2017 | 135.73 Mn |
| Dec 31, 2016 | 139.74 Mn |
| Sep 30, 2016 | 132.85 Mn |
| Jun 30, 2016 | 63.87 Mn |
| Mar 31, 2016 | 58.59 Mn |
| Dec 31, 2015 | 56.52 Mn |
| Sep 30, 2015 | 52.56 Mn |
| Dec 31, 2014 | 20.00 Mn |